Clinical Trial Update: Lipid Formulation to Increase the Bioavailability of Fatty Acids in Cystic Fibrosis (CF) Patients [NA]

View source ↗

Summary

A completed Nestlé-sponsored clinical trial evaluated a lipid formulation intended to increase the bioavailability of fatty acids in cystic fibrosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: Société des Produits Nestlé (SPN) | Conditions: Cystic Fibrosis | NA | Status: COMPLETED